US Broker Ratings

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with a Promising 12% Upside

In the dynamic and often volatile world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out for its innovative approach to tackling serious diseases. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Navigating Growth with a 43.5% Revenue Surge

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. With a market capitalization of $4.2 billion,..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotech Frontier with a 6.64% Potential Upside

In the ever-evolving landscape of biotechnology, PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out as a significant player. With its focus on rare disorders, the company is making strides in developing..

Haemonetics Corporation (HAE) Stock Analysis: Insights into a Promising Medical Device Leader with a 9.85% Upside

Haemonetics Corporation (NYSE: HAE) stands as a prominent player in the healthcare sector, specifically in the medical devices industry. With a market capitalization of $3.96 billion, the company has solidified..

Sotera Health Company (SHC) Stock Analysis: Healthcare Powerhouse with a 3.43% Potential Upside

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector, specializing in diagnostics and research, is catching the attention of investors with its robust service offerings and promising..

Rhythm Pharmaceuticals, Inc. (RYTM): Analyst Consensus and Growth Potential Amidst a 32% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on rare neuroendocrine diseases. Known for its flagship product, IMCIVREE, designed to address genetic obesity disorders,..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Pioneer with a Mixed Valuation Outlook

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a significant player in the biotechnology sector, focusing on pioneering treatments for rare genetic diseases. Headquartered in Cambridge, Massachusetts, Sarepta has carved a..

Inspire Medical Systems, Inc. (INSP): Investor Outlook with a 51.73% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a trailblazer in the healthcare sector, particularly within the medical devices industry, has garnered significant attention for its innovative approach to treating obstructive sleep..

Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator with Nearly 100% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to vaccine development. Focused on addressing bacterial infectious diseases, Vaxcyte’s..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Fuel Investor Optimism

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a leading entity in the biotechnology sector, is making waves with its promising growth trajectory and innovative product offerings. With a market capitalization of $8.27..

Integer Holdings Corporation (ITGR) Stock Report: Analyst Consensus and Growth Potential

Integer Holdings Corporation (NYSE: ITGR) stands as a pivotal player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plano, Texas, and with a market capitalization of..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unraveling the 140% Upside Potential

Soleno Therapeutics, Inc. (SLNO) is positioning itself as a significant player in the biotechnology sector with a focus on developing treatments for rare diseases. Headquartered in Redwood City, California, this..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Buy Ratings and 51.25% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the healthcare sector as a dynamic player in the biotechnology industry. With a market capitalization of $4.65 billion, the company has been..

Axsome Therapeutics (AXSM) Stock Analysis: Revenue Growth Soars Amid Biotech Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands as a compelling figure in the biotechnology sector, captivating investor attention with its impressive 63.20% revenue growth amidst the challenges of developing treatments for..

Glaukos Corporation (GKOS) Stock Analysis: A Promising 13.99% Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a leader in the healthcare sector focused on ophthalmic pharmaceuticals and medical technology, is capturing investor attention with an enticing potential upside of 13.99%. As a..

Masimo Corporation (MASI) Stock Analysis: Exploring a 44% Upside Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors seeking exposure to innovative patient monitoring technologies. Headquartered in..

Alkermes plc (ALKS) Stock Analysis: Unveiling a 55% Upside Potential for Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector and a key figure in the specialty and generic drug manufacturing industry, presents a compelling investment opportunity with substantial..

Bausch + Lomb Corporation (BLCO): Investor Outlook on Growth Potential and Strategic Positioning

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $5.87 billion,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 10.44% Upside Potential

Ionis Pharmaceuticals, Inc. (IONS), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its innovative RNA-targeted medicines. With a market capitalization of $12.9 billion,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside in Biotech Innovation

Investors searching for opportunities in the biotechnology sector might find Akero Therapeutics, Inc. (NASDAQ: AKRO) an intriguing prospect. This South San Francisco-based company, with a market capitalization of $4.5 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds